About: BLS Pharmaceuticals Limited manufactures, imports, exports, and supplies controlled drugs and prescription medicines in Australia, the United Kingdom, Europe, and Japan. It operates through Manufacture/Sales Australia, Plant Based/UK/EU/JPN/AUS, and Wholesale PCC/USA segments. The Manufacture/Sales Australia segment engages in the manufacture and wholesale supply of preventive and novel medicines, cannabis, psilocybin, and MDMA under BLS. The Plant Based/UK/EU/JPN/AUS segment manufactures and distributes consumer health and novel food products under the Dr Watson brand. The Wholesale PCC/USA segment is involved in wholesale of patented Probiotics for gastrointestinal health and immunity. It also provides contract manufacturing services; and storage and distribution services. The company was formerly known as Bioxyne Limited and changed its name to BLS Pharmaceuticals Limited in June 2026. BLS Pharmaceuticals Limited is headquartered in Sydney, Australia
Sector: Healthcare
Industry: Biotechnology
Latest price: A$1.02 (-0.49%)
BLS ASX Bls Pharmaceuticals Limited
Bls Pharmaceuticals Limited share price
BLS price activity
Last Price
$1.020
Change (24hr)
-0.01 AUD (-0.49%)
Volume
56.59K
Volume (4w avg)
-
Open
$1.05
Day Range
$1.01 - $1.05
Previous Close
$1.02
Last Trade
12 Oct, 5:10 am GMT+0
Delayed
12 Oct, 5:10 am GMT+0
BLS price performance
Delayed
12 Oct, 5:10 am GMT+0
BLS Market Signals